2018
Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT).
Hanlon A, Fleming S, Hamilton A, Dinan M, Melloni C, Harrison M, Khouri M, Wu X, Wilson J, Lipscomb J, Cress R, Anderson R, Kimmick G. Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT). Journal Of Clinical Oncology 2018, 36: 127-127. DOI: 10.1200/jco.2018.36.7_suppl.127.Peer-Reviewed Original ResearchUse of ADTAndrogen deprivation therapyProstate cancerRadiation therapyAdult Comorbidity Evaluation-27National Death Index dataPopulation-based cancer registriesEarly-stage prostate cancerAge 67.7 yearsCV risk factorsDefinitive radiation therapyDeath Index dataRisk of CVDCurative radiation therapyGleason score 3Hazard of deathCause of deathProstate cancer patternsHigher socioeconomic statusRace/ethnicityCV deathCVD equivalentDeprivation therapyHigher CVDCV disease
2017
Use of Whole Brain Radiation Therapy and Immune Checkpoint Inhibition in the Management of Brain Metastases
Savla B, Ahmed K, Yu M, Perez B, Dinan M, Mason N, Robinson T. Use of Whole Brain Radiation Therapy and Immune Checkpoint Inhibition in the Management of Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e105. DOI: 10.1016/j.ijrobp.2017.06.842.Peer-Reviewed Original Research
2015
Nationwide Utilization of Cardiac Imaging in Patients Undergoing External Beam Radiation Therapy With and Without Cardiotoxic Chemotherapy
Dinan M, Li Y, Reed S, Cheung W. Nationwide Utilization of Cardiac Imaging in Patients Undergoing External Beam Radiation Therapy With and Without Cardiotoxic Chemotherapy. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e368-e369. DOI: 10.1016/j.ijrobp.2015.07.1487.Peer-Reviewed Original ResearchLongitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer
Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD. Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer. Journal Of Palliative Medicine 2015, 18: 933-939. PMID: 26241733, PMCID: PMC4638209, DOI: 10.1089/jpm.2015.0171.Peer-Reviewed Original ResearchConceptsMetastatic prostate cancerProstate cancer metastasisRadiation therapyTreatment courseProstate cancerBony metastasesEnd Results-Medicare dataRadiation treatmentCancer metastasisCost-effective palliationPalliative radiation therapyPalliative radiation treatmentGeneral patient populationShort treatment courseHospital-based settingStudy inclusion criteriaTotal Medicare paymentsRadiation treatment courseRadiation therapy techniquesLack of evidencePalliative radiationPalliative settingPalliative treatmentClinical benefitPatient population
2014
Association Between Diagnostic CT Utilization and Radiation Therapy at the End of Life (EOL) in Elderly Breast and Prostate Cancer Patients: 2002-2007
Dinan M, Curtis L, Setoguchi-Iwata S, Cheung W. Association Between Diagnostic CT Utilization and Radiation Therapy at the End of Life (EOL) in Elderly Breast and Prostate Cancer Patients: 2002-2007. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s582. DOI: 10.1016/j.ijrobp.2014.05.1751.Peer-Reviewed Original ResearchAssociation between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients.
Dinan M, Curtis L, Setoguchi S, Cheung W. Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients. Journal Of Clinical Oncology 2014, 32: 6529-6529. DOI: 10.1200/jco.2014.32.15_suppl.6529.Peer-Reviewed Original ResearchRedistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non–Small-Cell Lung Cancer, 1998–2005
Dinan MA, Curtis LH, Carpenter WR, Biddle AK, Abernethy AP, Patz EF, Schulman KA, Weinberger M. Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non–Small-Cell Lung Cancer, 1998–2005. Journal Of Thoracic Oncology 2014, 9: 512-518. PMID: 24736074, DOI: 10.1097/jto.0000000000000102.Peer-Reviewed Original ResearchConceptsCell lung cancerTotal health care costsHealth care costsPositron emission tomographyProportion of patientsRate of surgeryMedicare beneficiariesLung cancerCare costsEmission tomographySurgical resectionInpatient costsRetrospective cohort studyYear of diagnosisMain outcome measuresCohort studyTreatment patternsOutcome measuresRadiation therapyChemotherapyPatientsRadiotherapyStudy periodCancerMedicare approval
2013
Changes in Radiation Therapy, Surgery, and Costs for Treatment of Non-Small Cell Lung Cancer After the Adoption of Positron Emission Tomography: 1998-2005
Dinan M, Curtis L, Carpenter W, Biddle A, Abernethy A, Patz E, Schulman K, Weinberger M. Changes in Radiation Therapy, Surgery, and Costs for Treatment of Non-Small Cell Lung Cancer After the Adoption of Positron Emission Tomography: 1998-2005. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s41-s42. DOI: 10.1016/j.ijrobp.2013.06.110.Peer-Reviewed Original ResearchLongitudinal trends in costs for palliative radiation for metastatic prostate cancer.
Robinson T, Dinan M, Li Y, Lee R, Reed S. Longitudinal trends in costs for palliative radiation for metastatic prostate cancer. Journal Of Clinical Oncology 2013, 31: 6554-6554. DOI: 10.1200/jco.2013.31.15_suppl.6554.Peer-Reviewed Original ResearchPalliative radiation therapyMetastatic prostate cancerProstate cancerRadiation therapyBony metastasesInclusion criteriaOutpatient facilitiesMedicare paymentsDistant metastatic diseaseTime of diagnosisPalliative radiation treatmentSEER-Medicare dataTreatment claimsStudy inclusion criteriaProstate cancer metastasisHealth care costsTotal Medicare paymentsAverage Medicare paymentsHealth care expendituresCarrier claimsPalliative radiationMetastatic diseasePalliative treatmentMedian ageMedian time
2012
Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999–2007
Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Lee WR, Schulman KA. Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999–2007. International Journal Of Radiation Oncology • Biology • Physics 2012, 82: e781-e786. PMID: 22331001, PMCID: PMC3418871, DOI: 10.1016/j.ijrobp.2011.11.024.Peer-Reviewed Original ResearchConceptsAndrogen deprivation therapyThree-dimensional conformal radiation therapyProportion of patientsInvasive radical prostatectomyOpen surgical approachProstate cancerIntensity-modulated radiation therapyRadiation therapyDeprivation therapyConformal radiation therapyRadical prostatectomySurgical approachMedicare populationRetrospective claims-based analysisIncident prostate cancerClaims-based analysisManagement of patientsLarge clinical trialsLocalized prostate cancerTreatment of patientsExternal beam radiotherapyHealth care costsActive therapyInitial treatmentOptimal therapy